General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Bayer(MODEST), BMS(MODEST), AstraZeneca(MODEST), Sanofi-Aventis(MODEST), Amgen (MODEST), Abbott(MODEST), Ascendia(MODEST), Lilly(MODEST), NonoNordisk(MODEST), Opalia(MODEST), Quantum Genomics(MODEST) RESEARCH/RESEARCH GRANTS: AstraZeneca(SIGNIFICANT), Sanofi-Aventis(SIGNIFICANT), Pfizer(SIGNIFICANT), BMS(SIGNIFICANT), Bayer(SIGNIFICANT), Abbott Laboratories(SIGNIFICANT), Amgen(SIGNIFICANT), Boehringer-Ingelheim(MODEST), Boston(MODEST), Novartis(MODEST), Quantum Genomics(MODEST), Terumo(MODEST)

View Full Disclosure